CVS Health Corporation [NYSE: CVS] stock went on an upward path that rose over 0.13% on Wednesday, amounting to a one-week price decrease of less than -1.95%. The company report on February 24, 2021 that CVS Health Will Administer COVID-19 Vaccines in Six Additional States.
Approximately 570,000 doses available across 17 states through latest allocation.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
CVS Health (NYSE: CVS) has added Alabama, Arizona, Florida, Louisiana, Ohio, and Pennsylvania to the list of states where select CVS Pharmacy locations will offer COVID-19 vaccinations to eligible populations through the Federal Retail Pharmacy Program. This follows the successful February 12 rollout in 11 states: California, Connecticut, Hawaii, Maryland, Massachusetts, New Jersey, New York, Rhode Island, South Carolina, Texas, and Virginia. Appointments for the latest allocation of approximately 570,000 doses will start to become available for booking, with shots beginning February 25.
Over the last 12 months, CVS stock rose by 10.38%. The one-year CVS Health Corporation stock forecast points to a potential upside of 19.47. The average equity rating for CVS stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $92.12 billion, with 1.31 billion shares outstanding and 1.31 billion shares in the current float. Compared to the average trading volume of 7.04M shares, CVS stock reached a trading volume of 6187232 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on CVS Health Corporation [CVS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVS shares is $85.72 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVS stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Jefferies have made an estimate for CVS Health Corporation shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 08, 2021. While these analysts kept the previous recommendation, Piper Sandler raised their target price to Overweight. The new note on the price target was released on September 17, 2020, representing the official price target for CVS Health Corporation stock. Previously, the target price had yet another raise to $72, while SVB Leerink analysts kept a Mkt Perform rating on CVS stock.
The Average True Range (ATR) for CVS Health Corporation is set at 1.52, with the Price to Sales ratio for CVS stock in the period of the last 12 months amounting to 0.34. The Price to Book ratio for the last quarter was 1.31, with the Price to Cash per share for the same quarter was set at 8.13. Price to Free Cash Flow for CVS in the course of the last twelve months was 8.53 with Quick ratio for the last quarter at 0.60.
CVS Stock Performance Analysis:
CVS Health Corporation [CVS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.95. With this latest performance, CVS shares dropped by -3.40% in over the last four-week period, additionally plugging by 11.12% over the last 6 months – not to mention a rise of 10.38% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVS stock in for the last two-week period is set at 41.04, with the RSI for the last a single of trading hit 38.90, and the three-weeks RSI is set at 43.72 for CVS Health Corporation [CVS]. The present Moving Average for the last 50 days of trading for this stock 71.74, while it was recorded at 68.94 for the last single week of trading, and 65.70 for the last 200 days.
Insight into CVS Health Corporation Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and CVS Health Corporation [CVS] shares currently have an operating margin of +5.18 and a Gross Margin at +18.24. CVS Health Corporation’s Net Margin is presently recorded at +2.68.
Return on Total Capital for CVS is now 9.04, given the latest momentum, and Return on Invested Capital for the company is 4.88. Return on Equity for this stock inclined to 10.79, with Return on Assets sitting at 3.11. When it comes to the capital structure of this company, CVS Health Corporation [CVS] has a Total Debt to Total Equity ratio set at 122.56. Additionally, CVS Total Debt to Total Capital is recorded at 55.07, with Total Debt to Total Assets ending up at 35.66. Long-Term Debt to Equity for the company is recorded at 112.36, with the Long-Term Debt to Total Capital now at 50.48.
Receivables Turnover for the company is 12.99 with a Total Asset Turnover recorded at a value of 1.16.CVS Health Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.60 and a Current Ratio set at 0.90.
CVS Stock EPS
With the latest financial reports released by the company, CVS Health Corporation posted 1.91/share EPS, while the average EPS was predicted by analysts to be reported at 1.63/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 17.20%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CVS Health Corporation go to 3.81%.
CVS Health Corporation [CVS] Insider Position Details
There are presently around $68,726 million, or 78.40% of CVS stock, in the hands of institutional investors. The top three institutional holders of CVS stocks are: VANGUARD GROUP INC with ownership of 105,383,923, which is approximately -0.728% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 92,478,369 shares of the stock with an approximate value of $6.38 billion in CVS stocks shares; and STATE STREET CORP, currently with $3.76 billion in CVS stock with ownership of nearly -3.595% of the company’s market capitalization.
Positions in CVS Health Corporation stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 1,113 institutional holders increased their position in CVS Health Corporation [NYSE:CVS] by around 57,816,088 shares. Additionally, 813 investors decreased positions by around 56,678,293 shares, while 133 investors held positions by with 881,105,678 shares. The mentioned changes placed institutional holdings at 995,600,059 shares, according to the latest SEC report filing. CVS stock had 258 new institutional investments in for a total of 7,277,454 shares, while 89 institutional investors sold positions of 5,197,953 shares during the same period.